David Gordon
2021 - Aclaris Therapeutics
In 2021, David Gordon earned a total compensation of $2.9M as Former Chief Medical Officer at Aclaris Therapeutics, a 284% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,606,689 |
|---|---|
| Salary | $424,453 |
| Stock Awards | $683,304 |
| Other | $206,663 |
| Total | $2,921,109 |
Gordon received $1.6M in option awards, accounting for 55% of the total pay in 2021.
Gordon also received $424.5K in salary, $683.3K in stock awards and $206.7K in other compensation.
Rankings
In 2021, David Gordon's compensation ranked 4,527th out of 12,415 executives tracked by ExecPay. In other words, Gordon earned more than 63.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,527 out of 12,415 | 64th |
Division Manufacturing | 1,873 out of 5,508 | 66th |
Major group Chemicals And Allied Products | 779 out of 2,378 | 67th |
Industry group Drugs | 693 out of 2,099 | 67th |
Industry Pharmaceutical Preparations | 494 out of 1,549 | 68th |
Source: SEC filing on April 21, 2022.
Gordon's colleagues
We found four more compensation records of executives who worked with David Gordon at Aclaris Therapeutics in 2021.
News
Aclaris Therapeutics CEO Neal Walker's 2021 pay jumps 326% to $6.9M
April 21, 2022
Coffee Holding Co CEO Andrew Gordon's 2021 pay slips 10% to $380K
February 28, 2022
Coffee Holding Co CEO Andrew Gordon's 2020 pay falls 66% to $421K
March 29, 2021
Aclaris Therapeutics CEO Neal Walker's 2019 pay falls 28% to $3.2M
April 23, 2020
Coffee Holding Co CEO Andrew Gordon's 2019 pay jumps 220% to $1.2M
February 28, 2020
Coffee Holding Co Secretary David Gordon's 2018 pay rises 2% to $389K
February 28, 2019